New
Pregnancy and Vitiligo
Pregnancy has a habit of ignoring project plans.
Sometimes the second child is carefully scheduled, prenatal vitamins are lined up on the kitchen counter, medications have already been reviewed, and everyone has had a sensible conversation with their doctors.
Sometimes there is a positive pregnancy test on Tuesday morning and the planning phase lasts approximately four minutes.
For women with vitiligo, either scenario tends to produce the same questions: Will pregnancy make my vitiligo worse? Does vitiligo make pregnancy riskier? Should I stop treatment? Could my baby inherit it? And if my first pregnancy was uneventful, does that tell me anything about the second?
A new 2026 systematic review gives us a useful opportunity to revisit these questions. The short version is reassuring. The longer version — inevitably — is more interesting.
Does pregnancy usually make vitiligo worse?
This sounds like something medicine ought to have settled decades ago. It hasn’t.
The newest systematic review, published in JEADV Clinical Practice in 2026, searched the literature through December 2024. The researchers initially found more than 1,700 records.
After all the screening? Five studies qualified.
And only two small cross-sectional studies, involving a combined 110 women, really provided useful information about how established vitiligo behaved during pregnancy.
What those limited data suggest is:
A few cases of vitiligo beginning for the first time during pregnancy have also been reported, but they appear uncommon.
The scientifically respectable answer is: pregnancy appears more likely to leave vitiligo alone than dramatically change it, but we cannot predict an individual woman’s course very well.
That may not make a great fortune cookie, but it is the correct advice.
Why would pregnancy change vitiligo at all?
Pregnancy is not simply nine months of higher estrogen.
The maternal immune system undergoes a substantial recalibration so that it can tolerate a fetus containing genetic material that is, biologically speaking, only half maternal. Regulatory immune pathways shift, hormone levels change dramatically, cortisol changes, and inflammatory signaling behaves differently.
Because vitiligo is an immune-mediated disease, it is entirely plausible that this altered immune environment could change its activity. But pregnancy does not suppress every autoimmune disease in the same way, and even women with the same condition can have very different experiences.
Vitiligo apparently belongs in the “mostly stable, occasionally better, occasionally worse” category.
Which, admittedly, describes quite a lot of parenting too.
What happens after delivery?
Childbirth is another enormous hormonal and immunological transition. Estrogen, progesterone and cortisol fall rapidly, pregnancy-related immune tolerance retreats, sleep becomes an endangered species, and psychological and physical stress can increase rather abruptly.
The actual vitiligo data remain small, but the studies available suggest that roughly 63–66% of women remain stable postpartum, while about 17–28% worsen.
That is not evidence for an inevitable postpartum flare. Quite the opposite: most women still remain stable.
But the first months after delivery are a reasonable time to keep an eye on previously active disease.
Does vitiligo make pregnancy dangerous?
This is where two related but different questions often get mixed together.
The picture is not perfectly clean. An Israeli study found no meaningful difference in adverse pregnancy outcomes, while larger Korean and Taiwanese database studies found higher rates of spontaneous pregnancy loss among women diagnosed with vitiligo.
In a large Taiwanese study, vitiligo was associated with about a 16% relative increase in the recorded risk of miscarriage.
Importantly, investigators did not find a significant overall increase in preterm delivery, pre-eclampsia/eclampsia, gestational diabetes, stillbirth or fetal growth restriction.
Vitiligo is associated with several autoimmune conditions, especially autoimmune thyroid disease, and those conditions can themselves affect pregnancy.
So the sensible conclusion in 2026 is not:
It is:
The thyroid deserves more attention than the white patches
If I were planning pregnancy with vitiligo, this is one of the items I would actually put on the checklist.
Vitiligo frequently travels with autoimmune thyroid disease. Untreated significant hypothyroidism or hyperthyroidism during pregnancy matters much more medically than depigmentation itself.
If you have vitiligo and are planning a pregnancy, mention it — along with any personal or family history of thyroid or other autoimmune disease — to your obstetrician or primary-care physician. They can decide whether thyroid testing is appropriate for you.
“Vitiligo is only cosmetic” is not a particularly useful medical philosophy. The skin may not be what causes the problem. Sometimes it is the signpost.
What if this is my second pregnancy?
If your first pregnancy was uncomplicated and your vitiligo stayed quiet, that is certainly reassuring.
It is not a contractual guarantee that pregnancy number two will behave identically.
Pregnancies differ. Your age may be different. Your thyroid status may be different. Your vitiligo may be more or less active. You may be using medications that did not exist or were not prescribed during pregnancy number one.
And then there is the small matter that pregnancy number two usually arrives in a household already containing child number one.
- Was my vitiligo active recently?
- Do I have another autoimmune condition?
- Has my thyroid been checked appropriately?
- What am I currently applying or taking?
- Did I have any significant pregnancy complications last time?
And what if the second pregnancy was a surprise?
Do not panic and do not perform your own overnight pharmacology review on Google.
A great many pregnancies begin while somebody is taking a medication that later needs to be reconsidered.
That does not automatically mean that damage has occurred. It means the medication list should be reviewed promptly.
Write down everything: prescription creams, tablets, injections, supplements, “natural” products, home phototherapy and over-the-counter treatments.
Then discuss the list with the clinician managing the pregnancy and, where needed, the dermatologist who prescribed your vitiligo treatment.
Pregnancy medicine is full of distinctions involving dose, timing, body surface area and trimester. “Safe” and “unsafe” are often much less binary than the internet makes them sound.
Vitiligo treatments during pregnancy: What’s safe?
This is where generic advice becomes dangerous, because vitiligo therapy has changed substantially in the last few years.
Narrowband UVB
Generally considered one of the more pregnancy-compatible treatment options. Adequate folate supplementation is also worth discussing because repeated UVB exposure can potentially reduce folate levels.
Topical corticosteroids
Commonly used during pregnancy on limited areas. Large cumulative amounts of very potent steroids require more caution. Dose matters. Area matters. Duration matters.
Ruxolitinib cream / Opzelura
This is the major update for 2026. Pregnancy data remain limited. European labeling states that Opzelura should not be used during pregnancy or breastfeeding. If you discover you are pregnant while using it, call your doctor rather than catastrophizing.
PUVA
Oral PUVA is considered contraindicated during pregnancy in international consensus recommendations and is no longer a routine treatment choice for vitiligo anyway.
Systemic treatments
Systemic corticosteroids and other immunomodulating medicines require individual assessment based on the drug, dose, disease activity, gestational timing and available alternatives.
Will my child inherit vitiligo?
Parents often hear two equally unhelpful answers.
Vitiligo is a polygenic, multifactorial disease. Many genetic variants contribute pieces of susceptibility, and non-genetic factors matter too.
If one parent has vitiligo, estimates of a child’s lifetime risk are generally in the neighborhood of 5–7%.
That is higher than the population average, but nowhere close to certainty.
Another useful clue comes from identical twins. They have essentially the same genome, yet when one identical twin has vitiligo, the other develops it only around 23% of the time in a major family study.
What if the father has it too?
Occasionally, parents ask about the double-whammy: What if both of us have vitiligo? Does the math just stack?
Not neatly.
Having two affected parents would reasonably be expected to increase a child’s genetic susceptibility, but vitiligo is polygenic and we do not have a reliable percentage that can predict the risk for an individual child in this situation.
The identical-twin data are a useful reminder why. Even when two people share essentially the same DNA, vitiligo is far from inevitable in both.
Should you test an unborn baby for “vitiligo genes”?
No routine clinical test can usefully tell you whether a fetus will later develop ordinary vitiligo.
There is no single “vitiligo gene.” Current genetics describes susceptibility and probabilities, not a yes-or-no prenatal diagnosis.
Does vitiligo affect fertility?
There is no convincing evidence that loss of pigment itself reduces female fertility.
If someone with vitiligo is having difficulty becoming pregnant, the usual fertility work-up remains appropriate. Do not automatically assume vitiligo explains it.
Again, associated thyroid disease matters more here than the color of the skin.
And breastfeeding?
Most of the same logic continues after delivery, but medications need another review because passage into breast milk becomes relevant.
NB-UVB is generally considered compatible with breastfeeding. Limited topical corticosteroids can usually be used with appropriate precautions; medication should not be left where an infant could directly ingest it from the skin.
Ruxolitinib cream deserves special attention: current European labeling contraindicates Opzelura during breastfeeding.
If postpartum vitiligo begins spreading, do not simply restart whatever you were using before pregnancy without checking whether it fits with breastfeeding.
Your dermatologist has probably heard stranger questions before breakfast.
What should I actually do before trying for another baby?
For most women with vitiligo, preparation can remain refreshingly boring.
- Tell your dermatologist you are planning. Review what you are currently using rather than waiting for the pregnancy test.
- Tell your obstetrician or primary-care clinician about the vitiligo. Discuss whether thyroid testing is appropriate for you.
- Review all medications and products. “It’s only a cream” is not an adequate medication review.
- Take standard preconception folic acid according to local medical guidance. This is particularly worth discussing if you are using NB-UVB.
- Mention your history. Previous miscarriages, thyroid disease, other autoimmune conditions or significant pregnancy complications all belong in the conversation.
- Have a postpartum plan. If you intend to breastfeed, know which treatments can be restarted and which may need to wait.
There is no special vitiligo pregnancy diet.
There is no supplement stack proven to stop your child from inheriting it.
And you do not need nine months of staring anxiously at the backs of your hands.
What the new paper really tells us
Perhaps the most important finding from the new systematic review is not the 65% stability figure.
It is how little high-quality research exists.
The review found just five eligible studies, and only two small cross-sectional studies — 110 women in total — meaningfully described the course of established vitiligo during pregnancy.
The authors also noted reliance on self-reporting, lack of standardized disease-activity measures, recall bias and incomplete documentation of treatment continuation.
The broad picture is reassuring. The precision is not yet where it should be.
Pregnancy is not some exotic complication affecting three people on another continent. Women with vitiligo have babies every day.
We should have better data.
If you have vitiligo and are thinking about pregnancy — whether baby number one has been planned for six months or baby number two has just announced itself without consulting the family calendar — the overall evidence remains reassuring.
Most women appear to have stable vitiligo during pregnancy. Some improve. Some worsen. Postpartum changes happen, but most women appear stable there too.
There may be a modest increase in miscarriage risk, although why this association exists remains uncertain. Other major pregnancy complications have not shown the same consistent increase.
The practical priorities are ordinary ones: review medications, pay attention to associated autoimmune disease — particularly thyroid disease — obtain good prenatal care, and involve your dermatologist when necessary. Vitiligo deserves sensible medical attention during pregnancy. It does not deserve control of the family-planning department.
Suggested Reading
Listen to the Podcast
Jukema MR, Gianotten E, Denswil NP, et al. The Impact of Pregnancy on the Course of Vitiligo—A Systematic Review . JEADV Clinical Practice. 2026.
International Vitiligo Task Force. Worldwide expert recommendations for the diagnosis and management of vitiligo .
European Medicines Agency. Opzelura (ruxolitinib) product information .
FAQOther Questions
- Which is better for judging vitiligo — Wood’s lamp or dermoscopy?
A recent study out of India compared the two head-to-head. Both tools correlated fairly well with clinical criteria, but dermoscopy had a slight edge: Wood’s lamp: sensitivity 7...
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
- Will it spread?
Vitiligo is famously unpredictable, but it doesn't move at random. By looking at thousands of cases, researchers have identified specific patterns of how the condition behaves. ...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.